ivermectin

Documents about ivermectin

• Anthelmintic resistance of gastrointestinal nematodes in cattle herds in mid-mountain central France#482432HAL (France)
• The World Health Organization year 2011 progress report: 1st September 2010 – 31st August 2011#133934WHO IRIS
• Modeling the impact of ivermectin-based optimal strategies on malaria control: the role of formulation, coverage, and mosquitocidal efficacy timing#161404HAL (France)
• Effect of pharmacokinetically-relevant ivermectin concentrations on survivorship and fecundity of Anopheles coluzzii and Aedes aegypti in Burkina Faso: A laboratory experimental study#308168HAL (France)
• Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer#463722ClinicalTrials.gov
• Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection.#869072ClinicalTrials.gov
• A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head Lice#908789ClinicalTrials.gov
• A Study Comparing Ivermectin Cream 1%, Soolantra™ Cream 1%, PrROSIVER® Cream1% to Placebo Control in the Treatment of Moderate to Severe Facial Rosacea.#914398ClinicalTrials.gov
• Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administration#803010ClinicalTrials.gov
• Impact of mass drug administration with Ivermectin, Diethylcarbamazine, and Albendazole in elimination of lymphatic filariasis in five districts of Nepal#127899PLOS
• Protocole de recherche pour suivre le choix des distributeurs communautaires et leur participation au TIDC : traitement à l'ivermectine sous directives communautaires#155917WHO IRIS
• Safety of the Co-administration of Three Drugs for Trachoma and Lymphatic Filariasis Elimination#845957ClinicalTrials.gov
• Mass Drug Administration for Lymphatic Filariasis and Onchocerciasis for Liberia#875889ClinicalTrials.gov
• Adjunctive Ivermectin Mass Drug Administration for Malaria Control#853012ClinicalTrials.gov
• Safety of a Single Dose of Moxidectin Compared With Ivermectin in Individuals Living in Onchocerciasis Endemic Areas and in Individuals Living in Onchocerciasis Endemic Areas With High Levels of Lymphatic Filariasis Co-endemicity Receiving Concomitant Albendazole#916892ClinicalTrials.gov